Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Andreas Varkaris, M.D., Ph.D.

Concepts (170)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Proto-Oncogene Proteins c-met320155781.030 Why?
src-Family Kinases320145490.860 Why?
Prostatic Neoplasms132023109990.760 Why?
Hyperinsulinism120244150.750 Why?
Receptors, Androgen3202310490.750 Why?
Phenylthiohydantoin120191900.640 Why?
Radium12016650.560 Why?
Interleukin-8120196850.540 Why?
Anilides320214050.490 Why?
Phosphatidylinositol 3-Kinases1202429330.480 Why?
Receptor, IGF Type 1220133900.470 Why?
Hepatocyte Growth Factor220132700.470 Why?
Vascular Endothelial Growth Factor Receptor-2120155450.430 Why?
Interleukin-62201931940.380 Why?
Insulin-Like Growth Factor I3201320150.370 Why?
Vascular Endothelial Growth Factor A2201935040.360 Why?
Class I Phosphatidylinositol 3-Kinases220248880.350 Why?
Neoplasms, Second Primary1201610450.330 Why?
Carcinoma, Renal Cell2202131010.320 Why?
Xenograft Model Antitumor Assays7201735620.290 Why?
Kidney Neoplasms2202141890.290 Why?
Liver Transplantation1201721100.280 Why?
Breast Neoplasms22024206760.280 Why?
Protein Kinase Inhibitors4202055020.280 Why?
Pyridines3202128100.270 Why?
Carcinoma, Hepatocellular1201721850.260 Why?
MicroRNAs2201937120.260 Why?
Carcinoma, Non-Small-Cell Lung2202051540.230 Why?
Prostate1201117430.220 Why?
Bone Neoplasms4201625210.220 Why?
Neoplasm Recurrence, Local2201991220.220 Why?
Antineoplastic Agents72020136350.210 Why?
Colorectal Neoplasms2201967260.210 Why?
Liver Neoplasms1201742160.210 Why?
Brain Neoplasms2202187910.200 Why?
Signal Transduction82023233550.200 Why?
Leukemia, Myeloid, Acute1201634850.190 Why?
Antineoplastic Combined Chemotherapy Protocols22019114100.190 Why?
Cryoelectron Microscopy120245670.190 Why?
Molecular Targeted Therapy1201127270.180 Why?
Fatal Outcome3202018500.180 Why?
Inflammation12019105340.170 Why?
Orchiectomy220114620.170 Why?
Phosphorylation5202384160.160 Why?
Hypernatremia12018820.160 Why?
Lung Neoplasms22020129850.160 Why?
Male2420233490220.150 Why?
Neoplasm Metastasis3201948320.150 Why?
Cell Transformation, Neoplastic2202029360.150 Why?
Progesterone120227720.150 Why?
Proto-Oncogene Proteins c-yes12015160.130 Why?
Hyponatremia120182960.130 Why?
Small Cell Lung Carcinoma120203840.130 Why?
Clinical Trials, Phase II as Topic220156180.130 Why?
Cell Line, Tumor72020166460.130 Why?
Focal Adhesion Kinase 1120151200.130 Why?
Humans2920247393980.130 Why?
Chitosan120151350.120 Why?
Nitriles120199460.120 Why?
Receptor, Fibroblast Growth Factor, Type 1120152500.120 Why?
Benzamides1201913740.120 Why?
Pyrazoles2202219630.110 Why?
Proto-Oncogene Proteins c-bcl-21202014310.110 Why?
Sodium1201816250.110 Why?
Ossification, Heterotopic120152380.110 Why?
Tumor Burden2201519040.110 Why?
Gene Expression Regulation, Neoplastic3201984000.110 Why?
Apoptosis4202097140.100 Why?
Neoplasms, Hormone-Dependent220134130.100 Why?
Taxoids220136610.100 Why?
Ubiquitin-Protein Ligases1202018490.090 Why?
Drug Resistance, Neoplasm2201551480.090 Why?
Gene Knockdown Techniques1201516540.090 Why?
Multicenter Studies as Topic1201515830.090 Why?
Gene Transfer Techniques1201512270.090 Why?
Lymphatic Metastasis1201728970.090 Why?
DNA1202472750.090 Why?
Neoplasm Transplantation1201320840.080 Why?
Bone Diseases120124170.080 Why?
Drug Design2201110880.080 Why?
Receptor, Insulin120128450.080 Why?
Aged820201626980.080 Why?
Prognosis22019289010.080 Why?
Integrins120138450.080 Why?
Disease-Free Survival1201968710.080 Why?
RNA Interference2201528990.080 Why?
Autophagy1201512950.080 Why?
Heart Diseases1202027820.080 Why?
Mice, Nude4201536920.080 Why?
Disease Models, Animal22017180030.070 Why?
Recurrence1201983070.070 Why?
Enzyme Activation1201337010.070 Why?
Female1020243788530.070 Why?
Mice82023810020.070 Why?
Animals1120231683680.070 Why?
Ligands1201333110.070 Why?
Cardiac Surgical Procedures1202035170.070 Why?
Survival Rate12019127610.070 Why?
Bone and Bones1201525750.060 Why?
Carcinoma, Squamous Cell1202040140.060 Why?
Cell Movement2201552210.060 Why?
Neoplasm Staging22017109610.060 Why?
Neovascularization, Pathologic1201426390.060 Why?
Nanoparticles1201519060.060 Why?
RNA, Small Interfering1201334980.060 Why?
Receptor Tyrosine Kinase-like Orphan Receptors12023420.060 Why?
Membrane Proteins1202078620.060 Why?
Randomized Controlled Trials as Topic1201998120.060 Why?
Protein Binding1201493750.050 Why?
Cell Proliferation52015104550.050 Why?
Pandemics1202082740.050 Why?
Follow-Up Studies22019389420.040 Why?
Mutation12024296580.040 Why?
Positron-Emission Tomography1201563610.040 Why?
Transcription, Genetic1201377090.040 Why?
Clinical Trials as Topic2201178970.040 Why?
Algorithms12018138720.040 Why?
Mitosis1202312120.040 Why?
Transfection2201558840.040 Why?
Ubiquitination1202010030.030 Why?
Thiazoles2201314880.030 Why?
Enzyme-Linked Immunosorbent Assay2201338630.030 Why?
Androgens1202312700.030 Why?
Disease Progression12011132370.030 Why?
Middle Aged520202128630.030 Why?
X-Ray Microtomography120154260.030 Why?
Stress, Physiological1202014050.030 Why?
Clinical Trials, Phase I as Topic120133150.020 Why?
Treatment Outcome22015626930.020 Why?
3T3 Cells1201311030.020 Why?
Neoplasms12020215070.020 Why?
Prostate-Specific Antigen2201124410.020 Why?
Multiple Myeloma1200951470.020 Why?
Up-Regulation1202042050.020 Why?
Triazines120123160.020 Why?
Pyrimidines2201329180.020 Why?
Immunoprecipitation120129030.020 Why?
Reverse Transcriptase Polymerase Chain Reaction1201547430.020 Why?
Aged, 80 and over32020576500.020 Why?
Osteoblasts1201311630.020 Why?
Mitochondria1202035220.020 Why?
Comorbidity12020103620.020 Why?
Prednisone1201115600.020 Why?
Infusions, Intravenous1201122700.020 Why?
Critical Illness1201826560.020 Why?
Intensive Care Units1201836720.020 Why?
Blotting, Western1201251810.020 Why?
Tumor Cells, Cultured1201263100.020 Why?
Cell Cycle1201229600.020 Why?
Proto-Oncogene Proteins c-akt1201225070.010 Why?
Administration, Oral1201139090.010 Why?
Drug Administration Schedule1201149350.010 Why?
Predictive Value of Tests12018150360.010 Why?
Drug Therapy, Combination1201264780.010 Why?
Prostatectomy1201118580.010 Why?
Immunohistochemistry12015113470.010 Why?
Time Factors22015400500.010 Why?
NF-kappa B1200925020.010 Why?
Weight Loss1201125890.010 Why?
Cohort Studies12021403890.010 Why?
Combined Modality Therapy1201186050.010 Why?
Retrospective Studies22021766310.010 Why?
Cell Survival1200958770.010 Why?
Enzyme Inhibitors1200938020.010 Why?
Prospective Studies12021530370.010 Why?
Pain1201149230.010 Why?
Young Adult12018562550.010 Why?
Antibodies, Monoclonal1200992590.010 Why?
Quality of Life12011126400.010 Why?
Adult120182133940.000 Why?
Varkaris's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (170)
Explore
_
Co-Authors (36)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.